MTCH
22
-17
VRSK
59
-2
HP
34
6
RF
63
5
MHK
37
-5
MTB
52
2
AVY
51
-2
MSI
47
4
MAS
60
9
LUV
62
-8
DRI
70
-2
GM
65
15
MPC
42
-2
SO
59
-5
RIG
25
-3
HOG
43
-2
FIS
75
-3
PDCO
69
-2
FE
60
-2
VTR
54
-6
MTCH
22
-17
VRSK
59
-2
HP
34
6
RF
63
5
MHK
37
-5
MTB
52
2
AVY
51
-2
MSI
47
4
MAS
60
9
LUV
62
-8
DRI
70
-2
GM
65
15
MPC
42
-2
SO
59
-5
RIG
25
-3
HOG
43
-2
FIS
75
-3
PDCO
69
-2
FE
60
-2
VTR
54
-6
Financhill
Back

ArrowMark Financial Vs. Sarepta Therapeutics Industry Stock Comparison

Sell
37

BANX
ArrowMark Financial

Last Price:
$20.75
Seasonality Move:
7.69%
Sell
48

SRPT
Sarepta Therapeutics

Last Price:
$74.08
Seasonality Move:
14.66%
Sell
37
ArrowMark Financial (BANX) is a Sell

Is ArrowMark Financial a Buy, Sell or Hold?

  • The current ArrowMark Financial [BANX] share price is $20.84. The Score for BANX is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
  • BANX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
48
Sarepta Therapeutics (SRPT) is a Sell

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $74.10. The Score for SRPT is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
  • SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

BANX Stock Price Chart

What is ArrowMark Financial's stock price today?

  • The ArrowMark Financial share price today is $20.84
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BANX is experiencing buying pressure, which is a positive indicator for future bullish movement.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $74.10
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing slight selling pressure.

BANX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 44.18 Sell
Chaikin Money Flow: 10673 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (20.92 - 21.24) Sell
Bollinger Bands (100): (20.62 - 21.2) Sell

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -8.7 Sell
Relative Strength Index (14 RSI): 27.9 Sell
Chaikin Money Flow: -367389 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (88.59 - 111.17) Sell
Bollinger Bands (100): (103.29 - 127.87) Sell

BANX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 21.07 Sell
20-day SMA: 21.09 Sell
50-day SMA: 21.06 Sell
200-day SMA: 20.26 Buy
8-day EMA: 21.03 Sell
20-day EMA: 21.08 Sell
50-day EMA: 21.04 Sell
200-day EMA: 20.3 Buy

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 87.22 Sell
20-day SMA: 97.87 Sell
50-day SMA: 108.64 Sell
200-day SMA: 125.16 Sell
8-day EMA: 84.58 Sell
20-day EMA: 94.74 Sell
50-day EMA: 105.16 Sell
200-day EMA: 118.38 Sell

ArrowMark Financial Earnings Growth & BANX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.52 per share, a decrease next quarter of $0.64 per share, an increase this year of $5.33 per share, and an increase next year of $5.23 per share.

ArrowMark Financial Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):